Updated Jul 16, 2026
Zalewski Thomas A. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Thomas A. Zalewski is an individual identified in connection with Aquestive Therapeutics, Inc. in the most recent SEC filing dated 2026-05-19. The available context does not clearly specify his exact role (e.g., officer, director, or beneficial owner) or provide additional biographical details. Based on the SEC context alone, he appears to be an insider or related party associated with Aquestive Therapeutics, but public biographical information beyond this filing is not available from the provided data.
| Role | Insider |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | AQST | Aquestive Therapeutics, Inc. | A — Grant or award | 100.0K | $0.00 |
Thomas A. Zalewski is an individual identified in connection with Aquestive Therapeutics, Inc. in the most recent SEC filing dated 2026-05-19. The available context does not clearly specify his exact role (e.g., officer, director, or beneficial owner) or provide additional biographical details. Based on the SEC context alone, he appears to be an insider or related party associa…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Zalewski Thomas A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.